Cohance Lifesciences Limited (NSE:COHANCE)
India · Delayed Price · Currency is INR 753.40
-25.55 (-3.28%)
Oct 31, 2025, 3:30 PM IST
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 288.23 billion as of October 31, 2025. Its market cap has decreased by -6.11% in one year.
Market Cap
288.23B
Enterprise Value
289.65B
Revenue
12.59B
Ranking
n/a
PE Ratio
80.19
Stock Price
753.40
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 288.23B, an increase of 855,043.40%. That is a compound annual growth rate of 396.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 288.23B | -0.57% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | 115.14B | 341,510.23% |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.09T |
| Divi's Laboratories | 1.77T |
| Cipla | 1.24T |
| Apollo Hospitals Enterprise | 1.12T |
| Mankind Pharma | 1.01T |
| Zydus Lifesciences | 992.30B |
| Fortis Healthcare | 788.63B |
| Alkem Laboratories | 660.60B |